Gamified training and AI aim to sharpen ear infection diagnoses

NCT ID NCT07246551

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a gamified training program for doctors, plus an AI tool that analyzes ear drum images, can improve the accuracy of diagnosing ear infections (otitis media). About 200 patients with ear symptoms will be seen by doctors who either received the training or standard care. The goal is to reduce misdiagnosis and unnecessary antibiotic use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

AOM Dx Trainer (gamified educational program)

What this could lead to

If successful, this could lead to more accurate ear infection diagnoses in primary care, reducing unnecessary antibiotic use and improving patient outcomes.

What could go wrong

This is a relatively small, early-stage trial (200 patients) focused on physician training, not a direct treatment. The AI tool is only being evaluated retrospectively, not used in real-time care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OTITIS MEDIA ACUTE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious otitis media otitis media otitis media with effusion

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••